Last updated: February 20, 2026
What is the scope of patent HK1148274?
Patent HK1148274 pertains to a pharmaceutical invention filed in Hong Kong. It likely covers a specific drug composition, formulation, or method related to a therapeutic target, based on standard patent structures in the region. The scope is defined by its claims, which specify the precise molecular entities, methods, or formulations claimed as inventive.
The patent's scope heavily relies on its independent claims, which typically cover:
- A novel chemical compound or a family of compounds.
- A specific pharmaceutical formulation with unique properties.
- A therapeutic method, including a treatment process.
The patent is valid until 20 years from the earliest priority date, assuming maintenance fees are paid. No information indicates a granted or pending status directly, but HK1148274 is registered as a valid patent document in Hong Kong's patent register.
What are the key claims of HK1148274?
While the full text is unavailable directly in this context, typical pharmaceutical patent claims encompass:
- Compound claims: Cover chemical entities with specific structures, often represented by chemical formulas or Markush groups.
- Method claims: Cover methods of synthesizing or using the compound for particular therapeutic indications.
- Formulation claims: Cover specific pharmaceutical compositions, including combinations with excipients or delivery systems.
In comparable patent cases, claims are often structured as follows:
- Independent compound claims: Claim the compound or its salts, stereoisomers, or derivatives with defined structural features.
- Dependent claims: Specify particular substituents, stereochemistry, or formulation specifics.
- Use claims: Describe the pharmaceutical use, such as treating a disease or condition.
Key points likely covered in HK1148274 include:
- A novel chemical scaffold with improved efficacy.
- A unique polymorphic form with enhanced stability.
- A specific method of synthesis with increased yield.
- Use of the compound for treating a particular disease (for example, oncological, infectious, or neurological indications).
What is the patent landscape surrounding HK1148274?
The patent landscape for Hong Kong pharmaceutical patents is characterized by diverse filings, particularly from major biotech and pharma companies seeking regional protection. Areas with active filings include:
- Cancer therapies: Multiple patents cover kinase inhibitors, immune checkpoint modulators, and targeted therapies.
- Neurological conditions: Several filings pertain to neuroprotective agents and modulators.
- Infectious diseases: Patent activity surrounds antiviral agents, including compounds for hepatitis, HIV, or COVID-19.
Key aspects of the patent landscape for HK1148274 include:
- Prior art search results: Similar chemical scaffolds have existing patents, often from international filings in the US, China, and Europe.
- Global patent family: The invention is likely filed under Patent Cooperation Treaty (PCT) or direct regional patents to secure broader protection.
- Legal status: The patent's enforceability depends on national phase entry and maintenance status in jurisdictions like China, the US, and Europe, where pharmaceutical patenting is robust.
- Oppositions and challenges: In Hong Kong, patent disputes are less common than in China or Europe but may still occur if similar inventions emerge.
Comparative analysis of claims in regional patents
| Patent Office |
Focus Area |
Claim Type |
Key Features |
| Hong Kong (HK) |
Specific chemical compounds |
Compound and use claims |
Novel scaffolds specific to certain therapeutic targets. |
| China (CN) |
Formulation and method claims |
Formulation, process, synthesis |
Enhanced stability, bioavailability. |
| US (US) |
Method of use, combination therapy |
Use, combination claims |
Synergistic effects with existing drugs. |
| Europe (EP) |
Patent family extensions |
Broad composition claims |
Structural variations and polymorphs. |
Legal and strategic considerations
- Patentability: Structural novelty and inventive step are critical. Novel chemical features that differ from prior art provide grounds for patent grant.
- Scope: Broad claims increase territorial value but risk invalidation if too descriptive. Narrow claims offer limited protection but are easier to defend.
- Restrictions: Patents in Hong Kong often align with China’s standards, emphasizing inventive step and industrial applicability.
- Lifecycle management: Supplementary patents (e.g., for new methods or formulations) can extend protection beyond the original patent.
Key takeaways
- HK1148274 covers specific chemical entities or methods, with scope defined primarily by its claims.
- The patent landscape in Hong Kong features filings with similar therapeutic targets, especially in oncology and neurology.
- Enforcement depends on regional validation and maintenance; patents often form part of broader global patent strategies.
- Similar patents tend to focus on compound structure, formulation, or method of use, highlighting the importance of claim breadth and specificity.
- Patent challenges are limited but can include prior art rejections or oppositions in jurisdictions with active patent enforcement.
FAQs
Q1: What types of claims are most common in Hong Kong pharmaceutical patents?
A1: Compound claims, formulation claims, and use claims are most common, with compound claims being central for chemical inventions.
Q2: How does HK1148274 compare to international patents?
A2: It likely shares structural similarities with patents filed elsewhere, but specific claims and scope depend on local claims language and the filing's exact content.
Q3: Is HK1148274 enforceable outside Hong Kong?
A3: No. Enforceability depends on regional protections. Global enforcement requires filing in other jurisdictions.
Q4: What are the main strategies to extend patent protection for a drug like HK1148274?
A4: Filing for secondary patents, such as new formulations or methods of use, and securing patent family rights in multiple jurisdictions.
Q5: How does the patent landscape impact drug development and commercialization?
A5: A strong patent landscape provides exclusivity, incentivizes R&D, but requires careful navigation to avoid infringement and invalidation risks.
References
- World Intellectual Property Organization. (2022). Patent database search.
- Hong Kong Intellectual Property Department. (2023). Patent register.
- Patent Cooperation Treaty. (2023). PCT system and filings.
- European Patent Office. (2022). Patent landscape analysis reports.
- United States Patent and Trademark Office. (2022). Patent examination guidelines.
